Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Jun 26, 2023 DEFA14A
DEF 14A Jun 26, 2023 DEF 14A
10-K May 22, 2023 10-K
8-K May 22, 2023 8-K
4 Apr 26, 2023 FORM 4
4 Apr 26, 2023 FORM 4
4 Apr 19, 2023 FORM 4
3 Apr 19, 2023 FORM 3
4 Apr 19, 2023 FORM 4
4 Apr 19, 2023 FORM 4
4 Apr 19, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
4 Apr 14, 2023 FORM 4
S-8 Apr 5, 2023 S-8
8-K Mar 27, 2023 8-K
SC 13G/A Feb 14, 2023
S-8 Feb 3, 2023 S-8
← Newer Page 13 of 26 · 642 filings Older →